Edgewise Therapeutics Inc (NASDAQ: EWTX) is -16.63% lower on its value in year-to-date trading and has touched a low of $14.90 and a high of $38.12 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EWTX stock was last observed hovering at around $22.80 in the last trading session, with the day’s loss setting it -0.54%.
Currently trading at $22.26, the stock is -12.69% and -15.92% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.99 million and changing -2.37% at the moment leaves the stock -12.29% off its SMA200. EWTX registered 36.98% gain for a year compared to 6-month loss of -15.97%. The firm has a 50-day simple moving average (SMA 50) of $26.5358 and a 200-day simple moving average (SMA200) of $25.35635.
The stock witnessed a -11.24% gain in the last 1 month and extending the period to 3 months gives it a -27.68%, and is -9.48% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.79% over the week and 8.30% over the month.
Edgewise Therapeutics Inc (EWTX) has around 110 employees, a market worth around $2.12B and $0.00M in sales. Distance from 52-week low is 49.40% and -41.61% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.90%).
The EPS is expected to shrink by -31.66% this year
278.0 institutions hold shares in Edgewise Therapeutics Inc (EWTX), with institutional investors hold 111.56% of the company’s shares. The shares outstanding are 94.84M, and float is at 67.23M with Short Float at 13.52%. Institutions hold 111.04% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 15.02 million shares valued at $270.54 million. The investor’s holdings represent 16.0634 of the EWTX Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 8.91 million shares valued at $160.45 million to account for 9.5269 of the shares outstanding. The other top investors are NOVO HOLDINGS A/S which holds 6.34 million shares representing 6.7844 and valued at over $114.26 million, while BLACKROCK INC. holds 6.4329 of the shares totaling 6.02 million with a market value of $108.34 million.
Edgewise Therapeutics Inc (EWTX) Insider Activity
The most recent transaction is an insider sale by Russell Alan J, the company’s Chief Scientific Officer. SEC filings show that Russell Alan J sold 200 shares of the company’s common stock on Mar 07 ’25 at a price of $30.02 per share for a total of $6004.0. Following the sale, the insider now owns 14863.0 shares.
Edgewise Therapeutics Inc disclosed in a document filed with the SEC on Mar 07 ’25 that KOCH KEVIN (President and CEO) sold a total of 100 shares of the company’s common stock. The trade occurred on Mar 07 ’25 and was made at $30.00 per share for $3000.0. Following the transaction, the insider now directly holds 14478.0 shares of the EWTX stock.
Still, SEC filings show that on Feb 05 ’25, Russell Alan J (Chief Scientific Officer) disposed off 8,015 shares at an average price of $30.02 for $0.24 million. The insider now directly holds 14,863 shares of Edgewise Therapeutics Inc (EWTX).
